Sun Pharma Receives South African Approval For Generic Semaglutide Posted: 16 Jul 2026, 3:04 PM IST 4m Sun Pharmaceutical Industries said it has received approval from the South African health regulator to make and market a generic version of a semaglutide injection for adults with inadequately controlled type 2 diabetes
And while not as prominent in the weight-loss space, Pfizer (NYSE: PFE) has recently doubled down on its efforts in that industry, signing a $2.1 billion licensing agreement in December 2025 with a Chinese pharmaceutical company to develop its early-stage weight-loss pill
Matza LS, Stewart KD, Land LF, Patel H, Boye KS (2022) Exit interviews examining the patient experience in clinical trials of tirzepatide for treatment of type 2 diabetes
Moretti M.E., Caprara D., Drehuta I., et al
Tan, T.M.M
I worry that its going to affect her self-esteem, she says